Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Nov 1, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- NIH Operates Under a Continuing Resolution
(NOT-OD-23-005)
National Institutes of Health
- Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2023 Councils
(NOT-OD-23-006)
National Institutes of Health
- Clarification and Guidance for Applicants Preparing Applications for the FALL 2022 Due Dates During the COVID-19 Pandemic
(NOT-OD-23-008)
National Institutes of Health
- NIH Offers Ability to Bypass 2-Business Day Application Viewing Window as an Option for Administrative Supplements
(NOT-OD-23-011)
National Institutes of Health
- Reminder: FORMS-H Grant Application Forms & Instructions Must be Used for Due Dates On or After January 25, 2023 - New Grant Application Instructions Now Available
(NOT-OD-23-012)
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar and Frequently Asked Questions (FAQs) for RFA-DK-22-018 "Human Islet Research Network (HIRN) Pancreas Knowledgebase Program (PanKbase) (U24 - Clinical Trial Not Allowed)"
(NOT-DK-22-033)
National Institute of Diabetes and Digestive and Kidney Diseases
- International Collaborations: Policies, Processes, & Partnerships NIH Virtual Event on November 9, 2022
(NOT-OD-23-009)
National Institutes of Health
- Notice of Termination for NOT-TR-22-023 NCATS Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
(NOT-TR-23-002)
National Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
- Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-296 NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required)
(NOT-CA-22-138)
National Cancer Institute
- Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-299 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required)
(NOT-CA-22-139)
National Cancer Institute
- Notice to Clarify Eligibility Requirements of Program Directors/Principal Investigators (PDs/PIs) in PAR-21-301 NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed)
(NOT-CA-22-141)
National Cancer Institute
- Notice of Corrected Application Forms for RFA-OD-22-017 Open Competition: Environmental influences on Child Health Outcomes (ECHO) Pregnancy Cohort Study Sites. Clinical Trial Not Allowed (UG3/UH3)
(NOT-OD-23-007)
Office of the Director, NIH
Notices of Special Interest
- Notice of Special Interest (NOSI): Supporting Womens Health Research in IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase 1 Program
(NOT-GM-23-012)
National Institute of General Medical Sciences
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Research through NCATS Clinical and Translational Science Award (CTSA) Program: High Impact Specialized Innovation Programs (RC2)
(NOT-TR-23-003)
National Center for Advancing Translational Sciences
Funding Opportunities
- Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
(PAR-22-239)
National Cancer Institute
- HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
(PAR-22-248)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
- Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
(PAR-22-249)
National Cancer Institute
- Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
(PAR-22-252)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of Mental Health
- Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
(PAR-23-032)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R24 Clinical Trials Not Allowed)
(PAR-23-039)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01)
(PAR-23-040)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).